TRAINING PROGRAM IN ACADEMIC MEDICAL ONCOLOGY/HEMATOLOGY

学术医学肿瘤学/血液学培训计划

• 批准号: 6632830
• 负责人: DAVID H BOLDT
• 金额: $ 6.59万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-07-01 至 2005-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6632830
• 关键词: TRAINING; PROGRAM; ACADEMIC; MEDICAL; ONCOLOGY

The purpose of this competing continuation Train Program Application is to extend the opportunity that exists at the University of Texas Health Science Center at San Antonio for the development and training of new physician/scientists in academic Medical Oncology and Hematology. This integrated 3 to 4-year program primarily for postdoctoral M.D. candidates (postdoc Ph.D. or Pharm.D.) candidates occasionally selected) begins with an intensive clinical year to obtain the experience necessary for board eligibility and/or translational research under the preceptorship of one of 17 outstanding and experienced faculty investigators. Research training is structured around 5 of the research programs sponsored by our NIH-designated Comprehensive Cancer Center (San Antonio Cancer Institute of SACI) including: Breast Cancer, Growth Factors, Drug Development, Molecular Genetics, and Cancer Prevention and Health Promotion. The faculty preceptors, representing 7 different departments, belong to one or more of these multi-departmental research programs. Research training is supplemented by unique formal coursework in medical writing and grant preparation, biostatistics methodology, clinical oncology, biology, molecular biology and ethics, and by a series of conferences, research seminars, data review sessions and research programs meetings. Medical Oncology trainees are selected from applicants who have completed a 3-year medical residency program. Trainees (2 Year 4 and 2 Year 5) selected for this Research Training Program must have a commitment to a career as a physician/scientist in academic medicine and must have a record of achievement indication promise as an academic investigator. Candidates with M.D. and Ph.D. degrees or those with prior laboratory research experience are given preference. Recruitment of minority trainees is also a goal to be accomplished through our Minority Recruitment Program that has been successful in the past. Trainees will engage in in depth training in one of several areas including and cellular biology of breast cancer, oncogenes and suppressor genes, regulation of gene expression, drug resistance, growth factors and signal transduction pathways, bone cell metabolism in malignancy, molecular genetics and hematopoietic stem cell differentiation. Research training is for a minimum of 2 years. These projects involve collaborations with faculty from other Cancer Center Research Programs and other UTHSCSA Departments, both clinical and basic science, to ensure an optimal training experience. Trainees completing this program will have acquired the clinical, research, teaching, and administrative skills that will provide them with a strong foundation for competitive research careers as physician/scientists.

此竞争性延续培训计划申请的目的是扩大圣安东尼奥德克萨斯大学健康科学中心现有的机会，以发展和培训学术肿瘤学和血液学方面的新医生/科学家。这个为期 3 至 4 年的综合项目主要针对博士后医学博士候选人（偶尔选择的博士后博士或药学博士候选人），从强化临床一年开始，以获得委员会资格和/或转化研究所需的经验。 17 名杰出且经验丰富的教职调查员之一的指导。研究培训围绕 NIH 指定综合癌症中心（SACI 圣安东尼奥癌症研究所）赞助的 5 个研究项目进行，包括：乳腺癌、生长因子、药物开发、分子遗传学以及癌症预防和健康促进。代表 7 个不同院系的教师导师属于这些多院系研究项目中的一个或多个。研究培训还辅以医学写作和拨款准备、生物统计学方法、临床肿瘤学、生物学、分子生物学和伦理学等独特的正式课程，以及一系列会议、研究研讨会、数据审查会议和研究项目会议。肿瘤内科实习生是从完成了 3 年住院医师计划的申请者中选拔的。入选本研究培训计划的学员（2名4年级和2名5年级）必须致力于学术医学领域的医生/科学家的职业生涯，并且必须拥有作为学术研究者的成就指示承诺记录。拥有医学博士和博士学位的候选人拥有学位或具有实验室研究经验者优先。招募少数族裔学员也是通过我们过去成功的少数族裔招聘计划来实现的目标。学员将在多个领域之一进行深度培训，包括乳腺癌细胞生物学、癌基因和抑制基因、基因表达调控、耐药性、生长因子和信号转导途径、恶性肿瘤中的骨细胞代谢、分子遗传学和造血干细胞分化。研究培训至少为期 2 年。这些项目涉及与其他癌症中心研究项目和 UTHSCSA 其他临床和基础科学部门的教师合作，以确保最佳的培训体验。完成该计划的学员将获得临床、研究、教学和管理技能，这将为他们作为医生/科学家的竞争性研究职业奠定坚实的基础。